Exhibit 10.2


 


REGISTRATION RIGHTS AGREEMENT


 


THIS REGISTRATION RIGHTS
AGREEMENT (this “Agreement”) is made as of ___, 2013, among MusclePharm Corporation, a Nevada corporation (the
“Company”), and each signatory hereto (each, an “Investor” and collectively, the “Investors”).


 


R E C I T A L S


 


WHEREAS, the Company
and the Investors are parties to Subscription Agreements (the “Subscription Agreements”), dated as of the date
hereof, as such may be amended and supplemented from time to time;


 


WHEREAS, the Investors’
obligations under the Subscription Agreements are conditioned upon certain registration rights under the Securities Act of 1933,
as amended (the “Securities Act”); and


 


WHEREAS, the Investors
and the Company desire to provide for the rights of registration under the Securities Act as are provided herein upon the execution
and delivery of this Agreement by such Investors and the Company.


 


NOW, THEREFORE, in
consideration of the promises, covenants and conditions set forth herein, the parties hereto hereby agree as follows:


 


1. Registration
Rights.


 


1.1 Definitions.
As used in this Agreement, the following terms shall have the meanings set forth below:


 


(a) “Commission”
means the United States Securities and Exchange Commission.


 


(b) “Common
Stock” means the Company’s common stock, par value $0.001 per share.


 


(c)  “Exchange
Act” means the Securities Exchange Act of 1934, as amended.


 


(d) “Filing
Date” means the date that is ninety (90) days after the Trigger Date.


 


(e)  “Investor”
means any person owning Registrable Securities who becomes party to this Agreement by executing a counterpart signature page hereto,
or other agreement in writing to be bound by the terms hereof, which is accepted by the Company.


 


(f) The terms “register,”
“registered” and “registration” refer to a registration effected by preparing and filing
a registration statement or similar document in compliance with the Securities Act, and the declaration or ordering of effectiveness
of such registration statement or document.


 






    	 



    	 



    

 


(g) “Registrable
Securities” means any of the Shares or any securities issued or issuable as (or any securities issued or issuable upon
the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect
to, or in exchange for, or in replacement of, the Shares; provided, however, that Registrable Securities shall not
include any securities of the Company that have previously been registered and remain subject to a currently effective registration
statement or which have been sold to the public either pursuant to a registration statement or Rule 144, or which have been sold
in a private transaction in which the transferor’s rights under this Section 1 are not assigned, or which may be sold immediately
without registration under the Securities Act and without restriction or imitation pursuant to Rule 144 and without the requirement
to be in compliance with Rule 144(c)(1).


 


(h) “Rule
144” means Rule 144 as promulgated by the Commission under the Securities Act, as such Rule may be amended from time
to time, or any similar successor rule that may be promulgated by the Commission.


 


(i) “Rule
415” means Rule 415 as promulgated by the Commission under the Securities Act, as such Rule may be amended from time
to time, or any similar successor rule that may be promulgated by the Commission.


 


(j)  “Shares”
means the shares of Common Stock issued pursuant to the Subscription Agreements,.


 


(k) “Trigger
Date” means the Final Closing Date (as defined in the Subscription Agreement).


 


1.2  Company
Registration.


 


(a) On or prior to
the Filing Date, the Company shall prepare and file with the Commission a registration statement covering the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. The registration statement shall be on Form S-1 or, if the
Company is so eligible, on Form S-3 (except if the Company is not then eligible to register for resale the Registrable Securities
on Form S-1 or Form S-3, as the case may be, in which case such registration shall be on another appropriate form in accordance
herewith) and shall contain (unless otherwise directed by Investors holding an aggregate of at least 75% of the Registrable Securities
on a fully diluted basis) substantially the “Plan of Distribution” attached hereto as Annex A. The Company
shall cause the registration statement to become effective and remain effective as provided herein. The Company shall use its reasonable
best efforts to cause the registration statement to be declared effective under the Securities Act as soon as practicable after
the Filing Date. The Company shall use its reasonable best efforts to keep the registration statement continuously effective under
the Securities Act until all Registrable Securities covered by such registration statement have been sold, or may be sold without
the requirement to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, as
determined by the counsel to the Company (the “Effectiveness Period”).


 






    	 



    	 



    

 


(b) The Company shall
pay to Investors a fee of 1.5% per month of the Investors’ investment, payable in cash, for every thirty (30) day period
up to a maximum of 5%, following the Filing Date that the registration statement has not been filed; provided, however,
that the Company shall not be obligated to pay any such liquidated damages if (i) the Registrable Securities that would other be
covered by the registration statement may be sold without the requirement to be in compliance with Rule 144(c)(1) and otherwise
without restriction or limitation pursuant to Rule 144 under the Securities Act or (ii) the Company is unable to fulfill its registration
obligations as a result of rules, regulations, positions or releases issued or actions taken by the Commission pursuant to its
authority with respect to “Rule 415”, and the Company registers at such time the maximum number of shares of Common
Stock permissible upon consultation with the staff of the Commission.


 


(c) If during the
Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then
registered in a registration statement, the Company shall file as soon as reasonably practicable an additional registration statement
covering the resale of not less than the number of such Registrable Securities.


 


(d) The Company shall
bear and pay all expenses incurred in connection with any registration, filing or qualification of Registrable Securities with
respect to the registrations pursuant to this Section 1.2 for each Investor, including (without limitation) all registration, filing
and qualification fees, printer’s fees, accounting fees and fees and disbursements of counsel for the Company, but excluding
any brokerage or underwriting fees, discounts and commissions relating to Registrable Securities and fees and disbursements of
counsel for the Investors.


 


(e) If at any time
during the Effectiveness Period there is not an effective Registration Statement covering all of the Registrable Securities, then
the Company shall notify each Investor in writing at least fifteen (15) days prior to the filing of any registration statement
under the Securities Act, in connection with a public offering of shares of Common Stock (including, but not limited to, registration
statements relating to secondary offerings of securities of the Company but excluding any registration statements (i) on Form S-4
or S-8 (or any successor or substantially similar form), or of any employee stock option, stock purchase or compensation plan or
of securities issued or issuable pursuant to any such plan, or a dividend reinvestment plan, (ii) otherwise relating to any employee,
benefit plan or corporate reorganization or other transactions covered by Rule 145 promulgated under the Securities Act, (iii)
on any registration form which does not permit secondary sales or does not include substantially the same information as would
be required to be included in a registration statement covering the resale of the Registrable Securities. In the event an Investor
desires to include in any such registration statement all or any part of the Registrable Securities held by such Investor, the
Investor shall within ten (10) days after the above-described notice from the Company, so notify the Company in writing, including
the number of such Registrable Securities such Investor wishes to include in such registration statement. If an Investor decides
not to include all of its Registrable Securities in any registration statement thereafter filed by the Company such Investor shall
nevertheless continue to have the right to include any Registrable Securities in any subsequent registration statement or registration
statements as may be filed by the Company with respect to the offering of the securities, all upon the terms and conditions set
forth herein.


 






    	 



    	 



    

 


1.3 Obligations
of the Company. Whenever required under this Section 1 to effect the registration of any Registrable Securities, the Company
shall, as expeditiously as reasonably possible:


 


(a) Prepare and file
with the Commission a registration statement with respect to such Registrable Securities and use its reasonable best efforts to
cause such registration statement to become effective and to keep such registration statement effective during the Effectiveness
Period;


 


(b) Prepare and file
with the Commission such amendments and supplements to such registration statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition
of all securities covered by such registration statement;


 


(c) Furnish to the
Investors such numbers of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the
Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities
owned by them (provided that the Company would not be required to print such prospectuses if readily available to Investors from
any electronic service, such as on the EDGAR filing database maintained at www.sec.gov);


 


(d) Use its reasonable
best efforts to register and qualify the securities covered by such registration statement under such other securities’ or
blue sky laws of such jurisdictions as shall be reasonably requested by the Investors; provided that the Company shall not be required
in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process
in any such states or jurisdictions;


 


(e) In the event of
any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the managing underwriter(s) of such offering (each Investor participating in such underwriting shall also enter into
and perform its obligations under such an agreement);


 


(f) Promptly notify
each Investor holding Registrable Securities covered by such registration statement at any time when a prospectus relating thereto
is required to be delivered under the Securities Act, within one business day, (i) of the effectiveness of such registration statement,
or (ii) of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect,
includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to
make the statements therein not misleading in the light of the circumstances then existing;


 


(g) Cause all such
Registrable Securities registered pursuant hereto to be listed on each securities exchange or nationally recognized quotation system
on which similar securities issued by the Company are then listed; and


 


(h) Provide a transfer
agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP number for all such Registrable Securities,
in each case not later than the effective date of such registration.


 






    	 



    	 



    

 


1.4 Furnish Information.
It shall be a condition precedent to the Company’s obligations to take any action pursuant to this Section 1 with respect
to the Registrable Securities of any selling Investor that such Investor shall furnish to the Company such information regarding
such Investor, the Registrable Securities held by such Investor, and the intended method of disposition of such securities in the
form attached to this Agreement as Annex B, or as otherwise reasonably required by the Company or the managing underwriters, if
any, to effect the registration of such Investor’s Registrable Securities.


 


1.5 Delay of
Registration. No Investor shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration
as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1.


 


1.6 Indemnification.


 


(a) To the extent
permitted by law, the Company will indemnify and hold harmless each Investor, any underwriter (as defined in the Securities Act)
for such Investor and each person, if any, who controls such Investor or underwriter within the meaning of the Securities Act or
the Exchange Act, against any losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons may
become subject under the Securities Act, the Exchange Act or other federal or state securities law, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions
or violations (collectively, a “Violation”): (i) any untrue statement or alleged untrue statement of a material
fact contained in a registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments
or supplements thereto (collectively, the “Filings”), (ii) the omission or alleged omission to state in the
Filings a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any
violation or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities law or any rule or
regulation promulgated under the Securities Act, the Exchange Act or any state securities law; and the Company will pay any legal
or other expenses reasonably incurred by any person to be indemnified pursuant to this Section 1.6(a) in connection with investigating
or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained
in this Section 1.6(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company
be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based
upon a Violation that occurs in reliance upon and in conformity with written information furnished expressly for use in connection
with such registration by any such Investor, underwriter or controlling person.


 


(b) To the extent
permitted by law, each Investor will indemnify and hold harmless the Company, each of its directors, each of its officers who has
signed the registration statement, each person, if any, who controls the Company within the meaning of the Securities Act or the
Exchange Act, any underwriter, any other Investor selling securities in such registration statement and any controlling person
of any such underwriter or other Investor, against any losses, claims, damages or liabilities (joint or several) to which any of
the foregoing persons may become subject under the Securities Act, the Exchange Act or other federal or state securities law, insofar
as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in
each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information
furnished by such Investor expressly for use in connection with such registration; and each such Investor will pay any legal or
other expenses reasonably incurred by any person to be indemnified pursuant to this Section 1.6(b) in connection with investigating
or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained
in this Section 1.6(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of the Investor (which consent shall not be unreasonably withheld); provided,
however, in no event shall any indemnity under this subsection 1.6(b) exceed the net proceeds received by such Investor
upon the sale of the Registrable Securities giving rise to such indemnification obligation.


 






    	 



    	 



    

 


(c) Promptly after
receipt by an indemnified party under this Section 1.6 of notice of the commencement of any action (including any governmental
action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section
1.6, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right
to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed,
to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified
party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right
to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified
party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between
such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice
to the indemnifying party within a reasonable time of the commencement of any such action, if materially prejudicial to its ability
to defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 1.6,
but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to
any indemnified party otherwise than under this Section 1.6.


 


(d) If the indemnification
provided for in Sections 1.6(a) and (b) is held by a court of competent jurisdiction to be unavailable to an indemnified party
with respect to any loss, claim, damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such
indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss,
claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one
hand and of the indemnified party on the other in connection with the statements or omissions or alleged statements or omissions
that resulted in such loss, liability, claim or expense as well as any other relevant equitable considerations. The relative fault
of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact relates to information supplied by the indemnifying party or by the indemnified
party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement
or omission. In no event shall any Investor be required to contribute an amount in excess of the net proceeds received by such
Investor upon the sale of the Registrable Securities giving rise to such indemnification obligation.


 






    	 



    	 



    

 


(e) The obligations
of the Company and Investors under this Section 1.6 shall survive the completion of any offering of Registrable Securities in a
registration statement under this Section 1, and otherwise.


 


1.7 Reports Under
Securities Exchange Act. With a view to making available the benefits of certain rules and regulations of the Commission, including
Rule 144, that may at any time permit an Investor to sell securities of the Company to the public without registration or pursuant
to a registration on Form S-1 or Form S-3, the Company agrees to:


 


(a) make and keep
public information available, as those terms are understood and defined in Rule 144, at all times after the Final Closing Date;


 


(b) take such action,
including the voluntary registration of its Common Stock under Section 12 of the Exchange Act, as is necessary to enable the Investors
to utilize Form S-1 for the sale of their Registrable Securities, such action to be taken as soon as practicable after the end
of the fiscal year in which the registration statement is declared effective;


 


(c) file with the
Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange
Act; and


 


(d) furnish to any
Investor, so long as the Investor owns any Registrable Securities, forthwith upon request (i) a written statement by the Company
that it has complied with the reporting requirements of Rule 144 the Securities Act and the Exchange Act (at any time after it
has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant
to Form S-1 or Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company
and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in
availing any Investor of any rule or regulation of the Commission that permits the selling of any such securities without registration
or pursuant to such form.


 


1.8 Transfer
or Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to this Section
1 may be transferred or assigned, but only with all related obligations, by an Investor to a transferee or assignee who (a) acquires
at least 25,000 Shares (subject to appropriate adjustment for stock splits, stock dividends and combinations) from such transferring
Investor, unless waived in writing by the Company, or (b) holds Registrable Securities immediately prior to such transfer or assignment;
provided, that in the case of (a), (i) prior to such transfer or assignment, the Company is furnished with written notice
stating the name and address of such transferee or assignee and identifying the securities with respect to which such registration
rights are being transferred or assigned, (ii) such transferee or assignee agrees in writing to be bound by and subject to the
terms and conditions of this Agreement and (iii) such transfer or assignment shall be effective only if immediately following such
transfer or assignment the further disposition of such securities by the transferee or assignee is restricted under the Securities
Act.


 






    	 



    	 



    

 


2. Legend.


 


(a) Each certificate
representing Shares of Common Stock held by the Investors shall be endorsed with the following legend:


 


“THE SECURITIES REPRESENTED BY
THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE
SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH
RESPECT TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL OF THIS CERTIFICATE THAT AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS
OF THE ACT IS AVAILABLE WITH RESPECT TO SUCH TRANSFER. ANY SUCH TRANSFER MAY ALSO BE SUBJECT TO COMPLIANCE WITH APPLICABLE STATE
SECURITIES LAWS.”


 


(b) The legend set
forth above shall be removed, and the Company shall issue a certificate without such legend to the transferee of the Shares represented
thereby, if, unless otherwise required by state securities laws, (i) such Shares have been sold under an effective registration
statement under the Securities Act, (ii) in connection with a sale, assignment or other transfer, such holder provides the Company
with an opinion of counsel, reasonably acceptable to the Company, to the effect that such sale, assignment or transfer is being
made pursuant to an exemption from the registration requirements of the Securities Act, or (iii) such holder provides the Company
with reasonable assurance that the Shares are being sold, assigned or transferred pursuant to Rule 144 or Rule 144A under the Securities
Act.


 


3. Miscellaneous.


 


3.1 Governing
Law. The parties hereby agree that any dispute which may arise between them arising out of or in connection with this Agreement
shall be adjudicated only before a federal court located in the State of New York and they hereby submit to the exclusive jurisdiction
of the federal and state courts of the State of New York with respect to any action or legal proceeding commenced by any party,
and irrevocably waive any objection they now or hereafter may have respecting the venue of any such action or proceeding brought
in such a court or respecting the fact that such court is an inconvenient forum, relating to or arising out of this Agreement or
any acts or omissions relating to the registration of the securities hereunder, and consent to the service of process in any such
action or legal proceeding by means of registered or certified mail, return receipt requested, in care of the address set forth
below or such other address as the undersigned shall furnish in writing to the other.


 


3.2 WAIVER OF
JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH
KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY


 


3.3 Waivers and
Amendments. This Agreement may be terminated and any term of this Agreement may be amended or waived (either generally or in
a particular instance and either retroactively or prospectively) with the written consent of the Company and Investors holding
at least a majority of the Registrable Securities then outstanding (the “Majority Investors”). Notwithstanding
the foregoing, additional parties may be added as Investors under this Agreement, and the definition of Registrable Securities
expanded, with the written consent of the Company and the Majority Investors. No such amendment or waiver shall reduce the aforesaid
percentage of the Registrable Securities, the holders of which are required to consent to any termination, amendment or waiver
without the consent of the record holders of all of the Registrable Securities. Any termination, amendment or waiver effected in
accordance with this Section 3.3 shall be binding upon each holder of Registrable Securities then outstanding, each future holder
of all such Registrable Securities and the Company.


 






    	 



    	 



    

 


3.4 Successors
and Assigns. Except as otherwise expressly provided herein, the provisions of this Agreement shall inure to the benefit of,
and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.


 


3.5 Entire Agreement.
This Agreement constitutes the full and entire understanding and agreement among the parties with regard to the subject matter
hereof, and no party shall be liable or bound to any other party in any manner by any warranties, representations or covenants
except as specifically set forth herein.


 


3.6 Notices.
All notices and other communications required or permitted under this Agreement shall be in writing and shall be delivered personally
by hand or by overnight courier, mailed by United States first-class mail, postage prepaid, sent by facsimile or sent by electronic
mail directed (a) if to an Investor, at such Investor’s address, facsimile number or electronic mail address set forth in
the Company’s records, or at such other address, facsimile number or electronic mail address as such Investor may designate
by ten (10) days’ advance written notice to the other parties hereto or (b) if to the Company, to its address, facsimile
number or electronic mail address set forth on its signature page to this Agreement and directed to the attention of its President,
or at such other address, facsimile number or electronic mail address as the Company may designate by ten (10) days’ advance
written notice to the other parties hereto. All such notices and other communications shall be effective or deemed given upon delivery,
on the date that is three (3) days following the date of mailing, upon confirmation of facsimile transfer or upon confirmation
of electronic mail delivery.


 


3.7 Interpretation.
The words “include,” “includes” and “including” when used herein shall be deemed in each case
to be followed by the words “without limitation.” The titles and subtitles used in this Agreement are used for convenience
only and are not considered in construing or interpreting this Agreement.


 


3.8 Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement, and the balance of the Agreement shall be interpreted as if such provision were so excluded, and shall be
enforceable in accordance with its terms.


 


3.9 Independent
Nature of Investors’ Obligations and Rights. The obligations of each Investor hereunder are several and not joint with
the obligations of any other Investor hereunder, and no Investor shall be responsible in any way for the performance of the obligations
of any other Investor hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no
action taken by any Investor pursuant hereto or thereto, shall be deemed to constitute the Investors as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert with respect
to such obligations or the transactions contemplated by this Agreement. Each Investor shall be entitled to protect and enforce
its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other
Investor to be joined as an additional party in any proceeding for such purpose.


 






    	 



    	 



    

 


3.10 Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall
constitute one instrument.


 


3.11 Telecopy
Execution and Delivery. A facsimile, telecopy or other reproduction of this Agreement may be executed by one or more parties
hereto, and an executed copy of this Agreement may be delivered by one or more parties hereto by facsimile or similar electronic
transmission device pursuant to which the signature of or on behalf of such party can be seen, and such execution and delivery
shall be considered valid, binding and effective for all purposes. At the request of any party hereto, all parties hereto agree
to execute an original of this Agreement as well as any facsimile, telecopy or other reproduction hereof.


 


[SIGNATURE PAGE FOLLOWS]


 






    	 



    	 



    

 


IN WITNESS WHEREOF,
the Company has caused this Agreement to be executed by its duly authorized officer, as of the date, month and year first set forth
above.


 


 


	 	MUSCLEPHARM CORPORATION
	 	 
	 	 
	 	By: 	 
	 	Name:
Title:	 
	 	 	 
	 	Address for notice:
	 	 
	 	4721 Ironton Street, Building A
	 	Denver, CO 80239



 


 


 


 


[COMPANY SIGNATURE PAGE TO REGISTRATION
RIGHTS AGREEMENT]


 



    	 



    	 



    

 


IN WITNESS WHEREOF,
the undersigned Investor has executed this Agreement as of the date, month and year that such Investor became the owner of Registrable
Securities.


 





	 	“Investor”
	 	 
	 	 
	 	 
	 	By: 	 
	 	Name:
Title:	 
	 	 	 
	 	Address for notice:
	 	 
	 	 
	 	 
	 	 
	 	Telephone:
	 	Facsimile:
	 	Email:



 


 


 


 


[INVESTOR COUNTERPART SIGNATURE PAGE
TO 


REGISTRATION RIGHTS AGREEMENT]


 



    	 



    	 



    

 


Annex A


 


Plan of Distribution


 


Each selling stockholder
of the common stock and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of
their shares of common stock on the Over-the-Counter Bulletin Board or any other stock exchange, market or trading facility on
which the shares are traded or in private transactions. These sales may be at fixed or negotiated prices. A selling stockholder
may use any one or more of the following methods when selling shares:


 


		·	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;



 


		·	block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the
block as principal to facilitate the transaction;



 


		·	purchases by a broker-dealer as principal and resale by the broker-dealer for its account;



 


		·	an exchange distribution in accordance with the rules of the applicable exchange;



 


		·	privately negotiated transactions;



 


		·	settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a
part;



 


		·	broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per
share;



 


		·	through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;



 


		·	a combination of any such methods of sale; or



 


		·	any other method permitted pursuant to applicable law.



 


The selling stockholders
may also sell shares under Rule 144 under the Securities Act of 1933, as amended, if available, rather than under this prospectus.


 


Broker-dealers engaged
by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction
not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction
a markup or markdown in compliance with FINRA IM-2440.


 






    	 



    	 



    

 


In connection with
the sale of the common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions
they assume. The selling stockholders may also sell shares of the common stock short and deliver these securities to close out
their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling
stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation
of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares
offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus
(as supplemented or amended to reflect such transaction).


 


The selling stockholders
and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within
the meaning of the Securities Act of 1933, as amended, in connection with such sales. In such event, any commissions received by
such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions
or discounts under the Securities Act of 1933, as amended. Each selling stockholder has informed us that it does not have any written
or oral agreement or understanding, directly or indirectly, with any person to distribute the common stock. In no event shall any
broker-dealer receive fees, commissions and markups which, in the aggregate, would exceed eight percent (8%).


 


We are required to
pay certain fees and expenses incurred by us incident to the registration of the shares. We have agreed to indemnify the selling
stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act of 1933, as
amended.


 


Because selling stockholders
may be deemed to be “underwriters” within the meaning of the Securities Act of 1933, as amended, they will be subject
to the prospectus delivery requirements of the Securities Act of 1933, as amended, including Rule 172 thereunder. In addition,
any securities covered by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act of 1933, as amended
may be sold under Rule 144 rather than under this prospectus. There is no underwriter or coordinating broker acting in connection
with the proposed sale of the resale shares by the selling stockholders.


 


We agreed to keep this
prospectus effective until the earlier of (i) the date on which the shares may be resold by the selling stockholders without registration
and without the requirement to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to
Rule 144 or (ii) all of the shares have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other
rule of similar effect. The resale shares will be sold only through registered or licensed brokers or dealers if required under
applicable state securities laws. In addition, in certain states, the resale shares may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and
is complied with.


 






    	 



    	 



    

 


Under applicable rules
and regulations under the Securities Exchange Act of 1934, as amended, any person engaged in the distribution of the resale shares
may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period,
as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholders will be subject
to applicable provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, including
Regulation M, which may limit the timing of purchases and sales of shares of the common stock by the selling stockholders or any
other person. We will make copies of this prospectus available to the selling stockholders and have informed them of the need to
deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172
under the Securities Act of 1933, as amended).


 



    	 



    	 



    

 


Annex B


 


Selling Securityholder Notice and Questionnaire


 


The undersigned beneficial owner of common
stock (the “Registrable Securities”) of MusclePharm Corporation, a Nevada corporation (the “Company”),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”)
a registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of the
Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with
the terms of the Registration Rights Agreement (the “Registration Rights Agreement”) to which this document
is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below.
All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.


 


Certain legal consequences arise from being
named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named
or not being named as a selling securityholder in the Registration Statement and the related prospectus.


 


NOTICE


 


The undersigned beneficial owner (the “Selling
Securityholder”) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration
Statement.


 


The undersigned hereby provides the following information to
the Company and represents and warrants that such information is accurate:


 


QUESTIONNAIRE


 


1. Name.


 


(a) Full Legal Name of Selling Securityholder


 


 


 



 


(b) Full Legal Name of Registered Holder
(if not the same as (a) above) through which Registrable Securities are held:


 


 


 



 


(c) Full Legal Name of Natural Control
Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities
covered by this Questionnaire):


 



    	 



    	 



    

 


2. Address for Notices to Selling Securityholder:


 


 



 

 



 


 



 


Telephone:


Fax:


Contact Person:



 


3. Broker-Dealer Status:


 


(a) Are you a broker-dealer?


 


Yes        No


 


(b) If “yes” to Section
3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?


 


Yes        No


 


Note: If “no” to Section
3(b), the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.


 


(c) Are you an affiliate of a broker-dealer?


 


Yes        No


 


(d) If you are an affiliate of a broker-dealer,
do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase
of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to
distribute the Registrable Securities?


 


Yes        No


 


Note: If “no” to Section
3(d), the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.


 


4. Beneficial Ownership of Securities of the Company Owned
by the Selling Securityholder.


 


Except as set forth below in this Item
4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Purchase Agreement.


 






    	 



    	 



    

 


 


 


(a) Type and Amount of other securities
beneficially owned by the Selling Securityholder:


 


 



 


 



 


5. Relationships with the Company:


 


Except as set forth below, neither the
undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors
or affiliates) during the past three years.


 


State any exceptions here:


 


 



 


 



 


The undersigned agrees to promptly notify
the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any
time while the Registration Statement remains effective.


 


By signing below, the undersigned consents
to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information
in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands
that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement
and the related prospectus.


 


IN WITNESS WHEREOF the undersigned, by
authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.


 


Date:


 


	 	Beneficial Owner:
	 	 
	 	 
	 	By: 	 
	 	 	Name:
Title:



 


 


 


 


[SIGNATURE PAGE FOR SELLING SECURITYHOLDER
NOTICE AND QUESTIONNAIRE]